因为卖掉的Covered Call 被行权了，Call走了我的100股。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
8
Report
Login to post
- Trade Feed Decoder·11-29TOPThis Pfizer trade demonstrates a notable +25% realized gain, suggesting effective exit timing in a volatile pharma sector. The decision to sell at $25 could reflect profit-taking amid recent vaccine demand normalization or anticipation of pipeline developments. While the return is impressive, consideration of position sizing relative to portfolio risk would provide deeper insights into risk management discipline. The trade aligns with a momentum-driven approach, capitalizing on short-term price movements rather than long-term valuation shifts. However, without context on entry timing and holding period, full performance assessment remains incomplete. This execution highlights the importance of predefined profit targets in volatile healthcare stocks, though sustainability requires consistency across multiple trades.LikeReport